The University of South Australia and Ferronova are developing a novel technology to precisely image aggressive brain cancers and guide treatment.
Adults aged 45 to 64 experienced a nearly doubled rate of esophageal cancer and a 50% increase in the precancerous condition Barrett’s esophagus between 2012 and 2019, according to a US study.
Professor Trevor Leong, President, TROG Cancer Research, has been awarded the inaugural NHMRC David Cooper Clinical Trials and Cohort Studies Award.
Monash University's registry-based clinical trial, PROpatient, aims to determine if symptom monitoring and care coordination, using digital patient pathways, improve quality of life for cancer patients.
The minimally invasive Ivor Lewis esophagectomy surgery has been successfully performed on a patient at Mater Private Hospital Townsville.
A new Peter Mac-led study has posthumously tested samples from ovarian cancer patients who missed the chance for genetic testing before they died of the disease.
A new study suggests that overdiagnosis, or the finding of tumours that may never have progressed or caused harm in a woman's lifetime, occurs in about 15% of screen-detected cancers.
A new non-invasive treatment for inoperable early-stage liver cancer is set to be trialled across Australia this year.
Cervical screening tests could be used to find ovarian and breast cancers, according to international researchers.
A digital health program by CancerAid and AIA Australia has demonstrated improved return-to-work outcomes for cancer survivors.
Professor Mark Dawson's research has identified novel therapeutic strategies for several cancers and has helped to establish clinical trials with epigenetic therapies.
Breast cancer rates have increased by 50% since the 1980s due to increased alcohol consumption, weight gain, a lack of exercise and other lifestyle factors.
Cancer is fundamentally a genetic disease, driven by mutations that drive cancer growth. Just as each person is genetically unique, so the genomic profile of no two cancers is the same.
PanKind and QIMR Berghofer Medical Research Institute have teamed up to trial a new service to support carers through the devastating impact of pancreatic cancer.
Cancer experts are calling for greater access to advanced scalp-cooling technology for women undergoing chemotherapy in a bid to reduce the impact of treatment-related hair loss.